115 related articles for article (PubMed ID: 28156086)
1. Upcoming Meetings Therapeutic Apheresis and Dialysis February 2017.
Ther Apher Dial; 2017 Feb; 21(1):110. PubMed ID: 28156086
[No Abstract] [Full Text] [Related]
2. Upcoming Meetings Therapeutic Apheresis and Dialysis February 2018.
Ther Apher Dial; 2018 Feb; 22(1):98. PubMed ID: 29405619
[No Abstract] [Full Text] [Related]
3. Role of apheresis and dialysis in pediatric living donor liver transplantation: a single center retrospective study.
Sanada Y; Mizuta K; Urahashi T; Ihara Y; Wakiya T; Okada N; Yamada N; Koinuma T; Koyama K; Tanaka S; Misawa K; Wada M; Nunomiya S; Yasuda Y; Kawarasaki H
Ther Apher Dial; 2012 Aug; 16(4):368-75. PubMed ID: 22817126
[TBL] [Abstract][Full Text] [Related]
4. Indian Society for Apheresis and apheresis tourism in India--is there a future?
Srivastava R
Transfus Apher Sci; 2006 Apr; 34(2):139-44. PubMed ID: 16516554
[TBL] [Abstract][Full Text] [Related]
5. Apheresis research-more abstracts should be published as full manuscripts to provide more evidence for clinical practice guidelines.
Pham HP; Jiang N; Pan Z; Williams LA; Marques MB
J Clin Apher; 2016 Aug; 31(4):353-8. PubMed ID: 26011563
[TBL] [Abstract][Full Text] [Related]
6. Sustained inhibition of oxidized low-density lipoprotein is involved in the long-term therapeutic effects of apheresis in dialysis patients.
Tsurumi-Ikeya Y; Tamura K; Azuma K; Mitsuhashi H; Wakui H; Nakazawa I; Sugano T; Mochida Y; Ebina T; Hirawa N; Toya Y; Uchino K; Umemura S
Arterioscler Thromb Vasc Biol; 2010 May; 30(5):1058-65. PubMed ID: 20203302
[TBL] [Abstract][Full Text] [Related]
7. Establishment of a national on-line registry for apheresis in Korea.
Song EY; Yoon JH; Lee JW; Park CW; Kwon SW; Kim DW; Lim YA; Kim HO; Han KS
Transfus Apher Sci; 2008 Apr; 38(2):93-100. PubMed ID: 18359274
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic apheresis in Asia: An Indonesia single center experience.
Triyono T; Vrielink H
J Clin Apher; 2015 Jun; 30(3):139-40. PubMed ID: 25116034
[TBL] [Abstract][Full Text] [Related]
9. Randomized controlled trials in therapeutic apheresis.
Winters JL
J Clin Apher; 2013 Feb; 28(1):48-55. PubMed ID: 23371830
[TBL] [Abstract][Full Text] [Related]
10. How we developed and use the American Society for Apheresis guidelines for therapeutic apheresis procedures.
Shaz BH; Schwartz J; Winters JL
Transfusion; 2014 Jan; 54(1):17-25. PubMed ID: 24261606
[TBL] [Abstract][Full Text] [Related]
11. Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.
Szczepiorkowski ZM; Bandarenko N; Kim HC; Linenberger ML; Marques MB; Sarode R; Schwartz J; Shaz BH; Weinstein R; Wirk A; Winters JL; ;
J Clin Apher; 2007 Jun; 22(3):106-75. PubMed ID: 17394188
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Apheresis and Dialysis: 20(th) Year of Publication.
Akizawa T
Ther Apher Dial; 2016 Feb; 20(1):5. PubMed ID: 26879489
[No Abstract] [Full Text] [Related]
13. Therapeutic apheresis for severe hypertriglyceridemia in pregnancy.
Basar R; Uzum AK; Canbaz B; Dogansen SC; Kalayoglu-Besisik S; Altay-Dadin S; Aral F; Ozbey NC
Arch Gynecol Obstet; 2013 May; 287(5):839-43. PubMed ID: 23479052
[TBL] [Abstract][Full Text] [Related]
14. Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.
Szczepiorkowski ZM; Winters JL; Bandarenko N; Kim HC; Linenberger ML; Marques MB; Sarode R; Schwartz J; Weinstein R; Shaz BH;
J Clin Apher; 2010; 25(3):83-177. PubMed ID: 20568098
[TBL] [Abstract][Full Text] [Related]
15. Apheresis activity in Spain: a survey of the Spanish Apheresis Group.
Lozano M; Cid J; Areal C; Romon I; Muncunill J;
Transfus Apher Sci; 2013 Dec; 49(3):560-4. PubMed ID: 24148714
[TBL] [Abstract][Full Text] [Related]
16. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue.
Schwartz J; Winters JL; Padmanabhan A; Balogun RA; Delaney M; Linenberger ML; Szczepiorkowski ZM; Williams ME; Wu Y; Shaz BH
J Clin Apher; 2013 Jul; 28(3):145-284. PubMed ID: 23868759
[TBL] [Abstract][Full Text] [Related]
17. Defining the role of lipoprotein apheresis in the management of familial hypercholesterolemia.
Lee WP; Datta BN; Ong BB; Rees A; Halcox J
Am J Cardiovasc Drugs; 2011 Dec; 11(6):363-70. PubMed ID: 22149315
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of low-density lipoprotein apheresis in patients with peripheral arterial occlusive disease undergoing hemodialysis treatment.
Morimoto S; Yano Y; Maki K; Sawada K; Iwasaka T
Am J Nephrol; 2007; 27(6):643-8. PubMed ID: 17878713
[TBL] [Abstract][Full Text] [Related]
19. Effects of selective LDL apheresis on plasma concentrations of ICAM-1, VCAM-1 and P-selectin in diabetic patients with arteriosclerosis obliterans and receiving maintenance hemodialysis.
Utsumi K; Kawabe M; Hirama A; Ueda K; Kamada Y; Arii K; Komaba Y; Katsura K; Iino Y; Katayama Y
Clin Chim Acta; 2007 Feb; 377(1-2):198-200. PubMed ID: 17126824
[TBL] [Abstract][Full Text] [Related]
20. Apheresis for MPO-ANCA-associated RPGN-indications and efficacy: lessons learned from Japan nationwide survey of RPGN.
Yamagata K; Hirayama K; Mase K; Yamaguchi N; Kobayashi M; Takahashi H; Koyama A
J Clin Apher; 2005 Dec; 20(4):244-51. PubMed ID: 15880406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
